These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23798457)

  • 1. Blood pressure targets in chronic kidney disease: does proteinuria dictate how low we go?
    Hildebrand AM; Garg AX
    CMAJ; 2013 Aug; 185(11):941-2. PubMed ID: 23798457
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic kidney disease: Blood pressure control in CKD--still a matter of debate.
    Ruilope LM
    Nat Rev Nephrol; 2013 Oct; 9(10):572-3. PubMed ID: 24018413
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis.
    Lv J; Ehteshami P; Sarnak MJ; Tighiouart H; Jun M; Ninomiya T; Foote C; Rodgers A; Zhang H; Wang H; Strippoli GF; Perkovic V
    CMAJ; 2013 Aug; 185(11):949-57. PubMed ID: 23798459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and kidney disease: what do the data really show?
    Cohen DL; Townsend RR
    Curr Hypertens Rep; 2012 Oct; 14(5):462-7. PubMed ID: 22814743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
    Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
    Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kidney in Hypertension.
    Sternlicht H; Bakris GL
    Med Clin North Am; 2017 Jan; 101(1):207-217. PubMed ID: 27884230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strict blood-pressure control and progression of renal failure in children.
    ; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
    N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure variability, cardiovascular risk, and risk for renal disease progression.
    Parati G; Ochoa JE; Bilo G
    Curr Hypertens Rep; 2012 Oct; 14(5):421-31. PubMed ID: 22903810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood pressure control in patient with chronic kidney disease].
    Halimi JM
    Ann Cardiol Angeiol (Paris); 2014 Jun; 63(3):209-12. PubMed ID: 24952677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing kidney disease with blood-pressure control.
    Wühl E; Schaefer F
    Nat Rev Nephrol; 2011 Jun; 7(8):434-44. PubMed ID: 21691318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which antihypertensive drugs are the most nephroprotective and why?
    Cravedi P; Ruggenenti P; Remuzzi G
    Expert Opin Pharmacother; 2010 Nov; 11(16):2651-63. PubMed ID: 20977400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood pressure targets in nephrology in 2017].
    Guerrot D; Godin M
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S69-S74. PubMed ID: 28577745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Educational paper: Progression in chronic kidney disease and prevention strategies.
    Schaefer B; Wühl E
    Eur J Pediatr; 2012 Nov; 171(11):1579-88. PubMed ID: 22968936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephrology update. Kidney protection with antihypertensive drugs: I].
    Stein G; Fünfstück R; Sperschneider H; Ritz E
    Med Klin (Munich); 2002 Sep; 97(9):541-6. PubMed ID: 12371082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Low Do We Go (in the Post-SPRINT Era)?
    Burgner A; Lewis JB
    Adv Chronic Kidney Dis; 2019 Mar; 26(2):110-116. PubMed ID: 31023444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment postpones end-stage renal failure in diabetic nephropathy.
    Hommel E; Mathiesen ER; Parving HH
    Scand J Urol Nephrol Suppl; 1988; 108():47. PubMed ID: 3163831
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antihypertensive therapy in chronic kidney disease: what targets and how to reach them].
    Bock A
    Ther Umsch; 2018; 75(6):365-369. PubMed ID: 30880625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive drugs and renal protection.
    Fukuda M; Usami T; Yoshida A; Kimura G
    JAMA; 2003 Mar; 289(9):1102-3; author reply 1103. PubMed ID: 12622571
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypertension and chronic renal insufficiency].
    Rosenkranz AR
    Acta Med Austriaca; 2001; 28(3):66-9. PubMed ID: 11475103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.